CN1884277A - Dibenzanthracene, dinaphthopyran and dibenzanthracene, dinaphtho spiropyran analog compound and its preparation - Google Patents
Dibenzanthracene, dinaphthopyran and dibenzanthracene, dinaphtho spiropyran analog compound and its preparation Download PDFInfo
- Publication number
- CN1884277A CN1884277A CN 200610014049 CN200610014049A CN1884277A CN 1884277 A CN1884277 A CN 1884277A CN 200610014049 CN200610014049 CN 200610014049 CN 200610014049 A CN200610014049 A CN 200610014049A CN 1884277 A CN1884277 A CN 1884277A
- Authority
- CN
- China
- Prior art keywords
- arh
- dinaphtho
- spiro
- carbon
- dinaphthopyran
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to dibenz, naphthopyrans and dibenz and dibenz spiropyran compound, and the method for preparing the same. Said method comprises: dibenzofuran or naphthofurans reacting with lithium with molar ration being 1:2-2.4, opening loop, reacting with aldehyde, ketone, ester or amide at temperature of -70 to -80 Deg. C, the molar ratio between dibenzofuran or naphthofurans and aldehyde, ketone, ester or amide is 1:0.7-1, dewatering and closing loop, and getting final product. The invention is characterized by cheap raw material, simple process, high productivity, and multiple kinds of products.
Description
Technical field
The present invention relates to a kind of dibenzo, dinaphthopyran and dibenzo, dinaphtho spiro-pyrans compounds and preparation method thereof.
Background technology
Pyran compounds is the very important organic heterocyclic molecule of a class, has a wide range of applications in a lot of fields.Wherein, the non-benzopyrans compounds that functional group replaces be the synthesis of natural product important intermediate (Danishefsk, S.J.Aldrich.Acta 1986,19,59; Schmidt, R.R.Acc.Chem.Res.1986,19,250).Therefore benzo, naphtho-pyrans compounds have been subjected to people's great attention because practical application is more widely arranged.Benzopyrans compounds is that a class has bioactive compound, for this compounds at pharmaceutically application existing a lot of report (Evans, J.M.; Stemp, G.Chem.Ber.1991,27,439; Attwood, M.R.; Jones, P.S.; Paciorek, P.B.; Redshaw, S.Life Sci.1991,48,803; Attwood, M.R.; Churcher, I.; Dunsdon, R.M.; Hurst, D.V.; Jones, P.S.Tetrahedron Lett.1991,32,811; Bergmann, R.; Eiermann, V.; Gericke, R.J.Med.Chem.1990,33,2759 etc.).Photochromic and thermochromism can take place greatly in benzo, aphthopyrans and benzo, naphtho-spiro-pyrans compounds on the other hand, therefore they have been widely used in aspect (Guglielmetti, R.J. such as light-sensitive sunglasses, electronic display system, optical switch and photo-memory material; Crano, J.C.Organic Photochromic and Thermochromic Compounds, Plenum Press, NewYork, 1998).
With respect to above-mentioned several compounds, for the report of dibenzo, dinaphthopyran compounds and research seldom, and do not have for the report of dibenzo, dinaphtho spiro-pyrans compounds at all.The method of now having reported for preparing dibenzo, dinaphthopyran compounds not only raw material is not easy to obtain, the step complexity, and total recovery is low, and the kind of this two compounds that can prepare seldom (Huang, C.-G.; Bereridge, K.A.; Wan, P.J.Am.Chem.Soc.1991,113,7676; Bringmann, G.; Schoner, B.; Peters, K.; Peters, E.; Von Schnering, H.G.Liebigs Ann.Chem.1994,439), this has just limited the research of people for these several compounds greatly, but in fact these several compounds have huge using value.For example, the natural product cannabinol is exactly a kind of dibenzopyrans compounds (Kogan, N.M.; Rabinowitz, R.; Levi, P.; Gibson, D.; Sandor, P.; Schlesinger, M.; Mechoulam, R.J.Med.Chem.2004,47,3800), it is a kind of narcotic that is widely used.American G.B.Schuster (J.Am.Chem.Soc.1998,120,12619) deep research has been carried out in a kind of reversible photoresponse of dinaphthopyran compounds, proposed it and probably be applied to the photoswitch that nematic liquid crystal and cholesteryl liquid crystal are changed mutually.
Therefore, we openly prepare the achievement in research of a series of dibenzo, dinaphthopyran and dibenzo, dinaphtho spiro-pyrans compounds here.
Summary of the invention
The object of the present invention is to provide a kind of method for preparing a series of dibenzo, dinaphthopyran and dibenzo, dinaphtho spiro-pyrans compounds by diphenylene-oxide (dibenzofuran) and one step of dinaphtho furans.
The general formula of dibenzopyrans and dibenzo spiro-pyrans compounds is (I):
R wherein
1, R
2: hydrogen atom, contain 1 to 20 carbon aliphatics substituting group, aromatic substituents, contain the aliphatics substituting group or the aromatic substituents of 1 to 20 carbon of aerobic, nitrogen, sulfur heteroatom; R
1, R
2Can Cheng Huan, be aliphatics substituting group, the aromatic substituents that contains 1 to 20 carbon, aliphatics substituting group or the aromatic substituents that contains 1 to 20 carbon of aerobic, nitrogen, sulfur heteroatom; R
1, R
2Can be identical, also can be different.
The general formula of dinaphthopyran and dinaphtho spiro-pyrans compounds is (II):
R wherein
1, R
2: hydrogen atom, contain 1 to 20 carbon aliphatics substituting group, aromatic substituents, contain the aliphatics substituting group or the aromatic substituents of 1 to 20 carbon of aerobic, nitrogen, sulfur heteroatom; R
1, R
2Can Cheng Huan, be aliphatics substituting group, the aromatic substituents that contains 1 to 20 carbon, aliphatics substituting group or the aromatic substituents that contains 1 to 20 carbon of aerobic, nitrogen, sulfur heteroatom; R
1, R
2Can be identical, also can be different.
The preparation method of described dibenzopyrans and dibenzo spiro-pyrans compounds, dinaphthopyran and dinaphtho spiro-pyrans compounds is: by diphenylene-oxide or dinaphtho furans and lithium by 1: the 2-2.4 molar ratio reaction, open loop, react with aldehyde, ketone, ester or acid amides at-70 ℃ to-80 ℃ then, the mol ratio of diphenylene-oxide or dinaphtho furans and aldehyde, ketone, ester or acid amides is 1: 0.7-1, dehydration closed-loop forms corresponding dibenzo, dinaphthopyran and dibenzo, dinaphtho spiro-pyrans compounds again.
The synthesis step of dibenzopyrans and dibenzo spiro-pyrans compounds is: with diphenylene-oxide, Tetramethyl Ethylene Diamine and lithium refluxed in ether 24 hours,-70 ℃ to-80 ℃ add aldehyde, ketone, ester or acid amides down, reaction rises to room temperature gradually, and room temperature reaction is after 12 hours, hydrolysis, pickling, dehydration is purified through separating, and can obtain corresponding product.
The synthesis step of dinaphthopyran and dinaphtho spiro-pyrans compounds is: with dinaphtho furans and lithium stirring at room 24 hours in ether,-70 ℃ to-80 ℃ add aldehyde, ketone, ester or acid amides down, reaction rises to room temperature gradually, behind the room temperature reaction 12 hours, hydrolysis, the acidifying dehydration is purified through separating, and can obtain corresponding product.
Its synthetic route such as Fig. 1, Fig. 2.
1-20 is the route synthetic compound by Fig. 1, also is the structural formula of compound among the embodiment
Wherein, compound 1-16 is the dibenzopyrans compounds, and 17-20 is a dibenzo spiro-pyrans compounds.
21-33 is the route synthetic compound by Fig. 2, also is the structural formula of compound among the embodiment
Wherein, compound 21-29 is the dinaphthopyran compounds, and 30-33 is a dinaphtho spiro-pyrans compounds.
The application of described dibenzopyrans and dibenzo spiro-pyrans compounds, dinaphthopyran and dinaphtho spiro-pyrans compounds is the application on medicine and photochromic material.
The beneficial effect of present method is that raw material is cheap and easy to get, and step is simple, the productive rate height, and the kind of dibenzo, dinaphthopyran and the dibenzo that can prepare, dinaphtho spiro-pyrans compounds is a lot.
Description of drawings
Fig. 1 is the synthetic route of dibenzopyrans and dibenzo spiro-pyrans compounds
Fig. 2 is the synthetic route of dinaphthopyran and dinaphtho spiro-pyrans compounds
Outstanding substantive distinguishing features of the present invention and unusual effect can be embodied from following example, but they do not impose any restrictions the present invention.
Embodiment
Embodiment 1
Compound 1-19's is synthetic:
In the 100mL there-necked flask of magneton is housed, add 0.153g (22mmol) lithium, 1.680g (10mmol) diphenylene-oxide, 3.30mL (22mmol) Tetramethyl Ethylene Diamine and 50mL exsiccant ether, reflux 24 hours.Add 0.59mL (8mmol) acetone down at-78 ℃, reaction rises to room temperature gradually, and stirring is spent the night.Slowly add the hydrolysis of 3N dilute hydrochloric acid then, separatory adds 20mL concentrated hydrochloric acid, stirring at room 2 hours, separatory, water CH in organic phase
2Cl
2Extract (20mL * 4), merge organic phase, wash with water, add anhydrous Na to neutrality
2SO
4Dry.Except that desolvating, cross Al with Rotary Evaporators
2O
3Post gets colorless oil 1.23g, productive rate 73%.The synthetic method of compound 2-19 and compound 1 are similar.Compound 1-19's
1H NMR,
13C NMR, MS, EA, mp and productive rate see Table 1-4.
Embodiment 2
Synthesizing of compound 20:
In the 100mL there-necked flask of magneton is housed, add 0.153g (22mmol) lithium, 1.680g (10mmol) diphenylene-oxide, 3.30mL (22mmol) Tetramethyl Ethylene Diamine and 50mL exsiccant ether, reflux 24 hours.Add 1.402g (8mmol) 1,3 down at-78 ℃, 3-trimethylammonium-2-indolone, reaction rises to room temperature gradually, and stirring is spent the night.Decompressing and extracting solvent and Tetramethyl Ethylene Diamine add the 50mL ether again, slowly add the hydrolysis of 3N dilute hydrochloric acid, separatory, organic phase is washed (20mL * 3) with 3N dilute hydrochloric acid again, merges water, slowly adds NaOH solution to neutral, there are a large amount of solids to separate out, filter, the solid CH that obtains
2Cl
2With the normal hexane recrystallization, get 2.04g lightpink crystal.Compound 20
1H NMR,
13CNMR, MS, EA, mp and productive rate see Table 1-4.
Embodiment 3
Compound 21-32's is synthetic:
In the 100mL there-necked flask of magneton is housed, add 0.153g (22mmol) lithium, 2.680g (10mmol) dinaphtho furans and 50mL exsiccant ether, stirring at room 24 hours.Add 0.59mL (8mmol) acetone down at-78 ℃, reaction rises to room temperature gradually, and stirring is spent the night.Slowly add the hydrolysis of 3N dilute hydrochloric acid next day, and separatory adds 20mL concentrated hydrochloric acid, stirring at room 2 hours, separatory, water CH in organic phase
2Cl
2Extract (20mL * 4), merge organic phase, wash with water, add anhydrous Na to neutrality
2SO
4Dry.Remove with Rotary Evaporators then and desolvate, cross Al
2O
3Post gets colorless solid 1.79g, productive rate 72%.The synthetic method of compound 22-32 and compound 21 are similar.Compound 21-32's
1H NMR,
13C NMR, MS, EA, mp and productive rate see Table 1-4.
Embodiment 4
Synthesizing of compound 33:
In the 100mL there-necked flask of magneton is housed, add 0.153g (22mmol) lithium, 2.680g (10mmol) dinaphtho furans and 50mL exsiccant ether, stirring at room 24 hours.Add 1.402g (8mmol) 1,3 down at-78 ℃, 3-trimethylammonium-2-indolone, reaction rises to room temperature gradually, and stirring is spent the night.Slowly add the hydrolysis of 3N dilute hydrochloric acid next day, separatory, and organic phase is washed (20mL * 3) with 3N dilute hydrochloric acid, merges water, slowly adds NaOH solution to neutral, has a large amount of solids to separate out, and filters, with solid CH
2Cl
2With the normal hexane recrystallization, get the 2.84g pale yellow crystals, productive rate 83%.Compound 33
1HNMR,
13C NMR, MS, EA, mp and productive rate see Table 1-4.
Table 1 compound 1-33's
1H NMR data
Comp. | 1H NMR(400MHz,in CDCl 3,ppm)(δ) |
1 | 1.71(s,6H,CH 3),7.03-7.10(m,2H,ArH),7.28-7.41(m,4H,ArH), 7.77-7.80(m,2H,ArH) |
2 | 1.63(t,3H,CH 2),1.69-1.73(m,2H,CH 2),1.80-1.93(m,4H,CH 2),2.13(d,J= 12.8Hz,2H,CH 2),7.01-7.05(m,2H,ArH),7.22-7.37(m,4H,ArH),7.73(d, J=6.8Hz,2H,ArH) |
3 | 1.52-1.66(m,4H,CH 2),1.71-1.77(m,2H,CH 2),1.85-1.93(m,2H,CH 2), 1.96-2.03(m,2H,CH 2),2.21-2.27(m,2H,CH2),6.97-7.03(m,2H,ArH), 7.20-7.35(m,4H,ArH),7.71(d,J=7.6Hz,2H,ArH) |
4 | 0.89(s,9H,CH 3),1.25-1.35(m,2H,CH 2),1.79-1.86(m,4H,CH 2),2.35(d,J= 13.6Hz,2H,CH 2),6.95(d,J=8Hz,1H,ArH),7.02(t,1H,ArH) 7.21-7.39(m,3H,ArH),7.53(d,J=7.2Hz,1H,ArH),7.70-7.73(m,2H,ArH) |
5 | 1.54(d,J=12.4Hz,2H,Ada H),1.74(s,2H,Ada H),1.80(d,J=13.2Hz,2H, AdaH),1.93(s,2H,AdaH),2.10(d,J=13.2Hz,2H,AdaH),2.36(s,2H, AdaH),2.53(d,J=12.4Hz,2H,AdaH),7.03-7.07(m,2H,ArH),7.25-7.38(m, 3H,ArH),7.69(d,J=7.6Hz,1H,ArH),7.75-7.77(m,2H,ArH) |
6 | 2.05(s,3H,CH 3),6.96(t,1H,ArH),7.04(d,J=7.6Hz,1H,ArH),7.17-7.44(m, 9H,ArH),7.66(d,J=8Hz,1H,ArH),7,76(d,J=7.6Hz,1H,ArH) |
7 | 6.72(d,J=8Hz,1H,ArH),6.95(t,1H,ArH),7.05(d,J=8Hz,1H,ArH), 7.16-7.27(m,12H,ArH),7.41(t,1H,ArH),7.66(d,J=8Hz,1H,ArH) |
8 | 6.20(s,1H,CH),6.89(d,J=7.6Hz,1H,ArH),7.04-7.10(m,2H,ArH), 7.24-7.29(m,2H,ArH),7.38-7.45(m,6H,ArH),7.78-7.81(m,2H,ArH) |
9 | 2.02(s,3H,CH 3),3.73(s,3H,OCH 3),6.75(d,J=8.8Hz,2H,ArH), 6.94-7.01(m,2H,ArH),7.17-7.26(m,5H,ArH),7.33(t,1H,ArH),7.41(t,1H, ArH),7.66(d,J=7.6Hz,1H,ArH),7.75(d,J=7.6Hz,1H,ArH) |
10 | 6.06(d,J=3.2Hz,1H,FurH),6.26(d,J=1.6Hz,1H,furH),6.32(s,1H,CH), 7.02-7.13(m,3H,ArH),7.23-7.26(m,1H,ArH),7.32(t,1H,FurH)7.45(t, 3H,ArH),7.77-7.82(m,1H,ArH) |
11 | cis:6.40(s,1H,CH=CH),6.44(s,1H,CH=CH),6.82(s,1H,CH=CH) 6.91-6.96(m,2H,ThiopheneH),7.05(t,1H,ArH),7.14(d,J=8Hz,1H, ThiopheneH),7.24-7.50(m,10H,ArH),7.75(d,J=8Hz,1H,ArH),7.84(d,J= 7.6Hz,1H,ArH) trans:6.82(s,1H,CH=CH),6.86(s,1H,CH=CH),6.91-6.96(m,2H, ThiopheneH),7.05(t,1H,ArH),7.14(d,J=8Hz,1H,ThiopheneH), 7.24-7.50(m,10H,ArH),7.75(d,J=8Hz,1H,ArH),7.84(d,J=7.6Hz,1H, ArH) |
12 | cis:6.12(s,1H,CH=CH),6.16(s,1H,CH=CH),1.91(s,3H,CH 3),6.16(s,1H, FurH),6.31(t,1H,FurH),7.03(t,2H,ArH),7.23-7.43(m,ArH,FurH), 7.73-7.79(m,1H,ArH) trans:6.39(s,1H,CH=CH),6.43(s,1H,CH=CH),1.91(s,3H,CH 3),6.16(s, 1H,FurH),6.31(t,1H,FurH),7.03(t,2H,ArH),7.23-7.43(m,ArH,FurH), 7.73-7.79(m,1H,ArH) |
13 | 2.25-2.32(m,1H,CH 2),2.67-2.74(m,1H,CH 2),2.89-2.96(m,1H,CH 2), 3.14-3.21(m,1H,CH 2),6.77(d,J=7.6Hz,1H,ArH),6.95(d,J=8Hz,1H, ArH),7.07(t,1H,ArH),7.18-7.31(m,3H,ArH),7.35-7.39(m,4H,ArH), 7.81(d,J=7.6Hz,2H,ArH) |
14 | 1.86(s,3H,CH 3),4.46(s,9H,FcH),6.83-7.25(m,6H,ArH),7.68(s,2H,ArH) |
15 | 3.98-4.19(m,9H,FcH)5.98(s,1H,CH)7.02-7.37(m,6H,ArH)7.73(s, 2H,ArH) |
16 | 6.59(d,J=7.6Hz,1H,ArH),6.92(d,J=8Hz,1H,ArH),7.06(t,1H,ArH), 7.12-7.19(m,3H,ArH),7.22-7.29(m,2H,ArH),7.34-7.41(m,3H,ArH), 7.69(d,J=7.6Hz,2H,ArH),7.89(d,J=3.2Hz,1H,ArH),7.90(d,J=3.6Hz, 1H,ArH) |
17 | 6.28(d,J=9.6Hz,1H,CH=CH)6.77(d,J=8Hz,1H,CH=CH) 6.96-7.30(m,7H,ArH)7.40-7.57(m,3H,ArH)7.95(t,2H,ArH) |
18 | 6.39(d,J=10Hz,1H,CH=CH),6.89(d,J=8Hz,1H,CH=CH),6.97(d,J= 8.8Hz,1H,ArH),7.15(t,1H,ArH),7.25(t,1H,ArH),7.40-7.44(m,2H,ArH), 7.52-7.60(m,3H,ArH),7.69(d,J=8.8Hz,1H,ArH),7.78-7.84(m,1H,ArH), 7.93-7.98(m,2H,ArH),8.18(d,J=8.4Hz,1H,ArH) |
19 | 6.90(d,J=8Hz,2H,ArH),7.15-7.35(m,8H,ArH),7.54-7.58(m,2H,ArH), 7.97(d,J=7.6Hz,2H,ArH),8.03(d,J=8Hz,2H,ArH) |
20 | 0.87(s,3H,CH 3),1.22(s,3H,CH 3),2.89(s,3H,N-CH 3),6.71(d,J=7.7Hz, 1H,ArH),6.89(t,1H,ArH),6.97-7.01(m,1H,ArH),7.06(d,J=7.1Hz,1H, ArH),7.18-7.22(m,1H,ArH),7.24-7.29(m,1H,ArH) |
21 | 1.44(s,3H,CH 3),1.98(s,3H,CH 3),7.29-7.42(m,4H,ArH),7.47-7.53(m,2H, ArH),7.65(d,J=8.5Hz,1H,ArH),7.72(d,J=8.6Hz,1H,ArH), 7.86-7.92(m,4H,ArH) |
22 | 2.18(s,3H,CH 3),6.96-7.06(m,3H,ArH),7.19(t,1H,ArH),7.27-7.32(m,4H, ArH),7.38(d,J=8.7Hz,1H,ArH),7.51(t,1H,ArH),7.97(d,J=8.2Hz,1H, ArH),8.03(d,J=8.4Hz,1H,ArH) |
23 | 1.33-1.38(m,2H,CH 2),1.47-1.51(m,2H,CH 2),1.83-1.88(m,2H,CH 2), 2.04-2.21(m,3H,CH 2),2.31-2.37(m,1H,CH 2),7.28-7.31(m,2H,ArH), 7.35-7.47(m,3H,ArH),7.53(d,J=8.5Hz,1H,ArH),7.60(d,J=8.5Hz,1H, ArH),7.69(d,J=8.7Hz,1H,ArH),7.84-7.90(m,4H,ArH) |
24 | 1.23(d,J=12.1Hz,1H,AdaH),1.57(d,J=13.3Hz,1H,AdaH),1.71(t,2H, AdaH),1.85(s,2H,AdaH),1.96(s,2H,AdaH),2.06(d,J=20.3Hz,2H, AdaH),2.22(d,J=13.29Hz,1H,AdaH),2.68(s,1H,AdaH),3.01(d,J=12.4 Hz,2H,AdaH),7.26(t,1H,ArH),7.36-7.49(m,4H,ArH),7.75(d,J=8.7Hz, 1H,ArH),7.81(d,J=8.2Hz,1H,ArH),7.87-7.95(m,4H,ArH),8.12(d,J= 8.7Hz,1H,ArH) |
25 | 6.94(d,J=8.4Hz,1H,ArH),7.06(s,3H,ArH),7.19-7.41(m,1H,ArH),7.49(t, 1H,ArH),7.54(d,J=8.4Hz,1H,ArH),7.72-7.77(m,4H,ArH),7.89(d,J= 8.2Hz,1H,ArH) |
26 | 5.97(s,1H,CH),6.83-6.85(m,1H,ArH),7.34-7.56(m,10H,ArH), 7.74-7.80(m,3H,ArH),7.89-7.94(m,3H,ArH) |
27 | 1.69(s,3H,CH 3),4.27-4.58(m,9H,FcH),7.03(d,J=6.8Hz,1H,ArH), 7.25-7.42(m,5H,ArH),7.66-7.72(m,3H,ArH),7.81(d,J=7.2Hz,1H,ArH), 7.91(d,J=7.3Hz,2H,ArH) |
28 | 4.38(s,8H,FcH),4.50(s,1H,FcH),5.61(s,1H,CH),7.09(d,J=8.4Hz,1H, ArH),7.28-7.48(m,4H,ArH),7.54(d,J=8.7Hz,1H,ArH),7.73-7.77(m,3H, ArH),7.86(d,J=8.1Hz,1H,ArH),7.92-7.95(m,2H,ArH) |
29 | 6.53(d,J=7.7Hz,1H,ArH),6.71(t,1H,ArH),6.83(d,J=8.42Hz,1H,ArH), 7.25(t,1H,ArH),7.33-7.56(m,8H,ArH),7.66-7.69(m,2H,ArH), 7.78-7.81(m,2H,ArH),7.87(t,3H,ArH),7.95(d,J=8.1Hz,1H,ArH) |
30 | 6.29(d,J=9.7Hz,1H,CH=CH),6.53(d,J=8.1Hz,1H,CH=CH), 7.00-7.03(m,1H,ArH),7.10-7.13(m,1H,ArH),7.18(d,J=9.7Hz,1H,ArH), 7.29-7.39(m,3H,ArH),7.43-7.46(m,1H,ArH),7.54-7.58(m,1H,ArH) 7.66(d,J=8.4Hz,1H,ArH),7.83-8.00(m,7H,ArH) |
31 | 6.45(d,J=9.9Hz,1H,CH=CH),6.75(d,J=8.9Hz,1H,CH=CH),7.21(d,J= 8.6Hz,1H,ArH),7.38-7.48(m,4H,ArH),7.56-7.64(m,3H,ArH),7.73(d,J= 8.4Hz,1H,ArH),7.79(d,J=8.1Hz,1H,ArH),7.84(d,J=8.7Hz,1H,ArH), 7.88-8.02(m,6H,ArH),8.22(d,J=8.7Hz,1H,ArH) |
32 | 6.55-6.58(m,1H,ArH),7.12-7.24(m,3H,ArH),7.34-7.45(m,5H,ArH), 7.56-7.62(m,2H,ArH),7.79-8.08(m,9H,ArH) |
33 | 0.95(s,3H,CH 3),1.12(s,3H,CH 3),2.82(s,3H,N-CH 3),6.71(d,J=7.5Hz, 1H,ArH),6.87(t,1H,ArH),7.01(d,J=7.1Hz,1H,ArH),7.26-7.43(m,5H, ArH),7.54(t,1H,ArH),7.61(d,J=8.3Hz,1H,ArH),7.67(d,J=8.2Hz,1H, ArH),7.75(d,J=8.6Hz,1H,ArH),7.81(d,J=8.7Hz,1H,ArH),7.88(t,2H, ArH),7.94(d,J=8.2Hz,1H,ArH) |
Table 2 compound 1-33's
13C NMR data
Comp. | 13C NMR(400MHz,in CDCl 3,ppm)(δ) |
1 | 27.9,77.8,118.3,121.8,122.5,122.6,123.2,123.5,128.0,128.3,128.9,129.7, 139.8,153.0 |
2 | 21.6,25.4,34.6,77.6,118.0,121.5,122.3,122.8,122.9,123.1,127.5,127.9, 129.0,129.2,139.9,152.8 |
3 | 23.0,29.9,39.5,82.0,118.4,121.7,122.4,123.0,123.1,123.5,127.7,128.1, 128.8,129.6,141.7,152.7 |
4 | 24.8,27.9,32.7,36.3,47.1,78.3,118.3,121.7,122.9,123.2,123.8,124.9,127.4, 127.8,129.7,130.0,139.2,153.2 |
5 | 26.9,27.2,33.9,34.4,35.0,38.1,80.9,118.2,121.4,122.2,123.7,125.4,125.5, 126.9,127.4,129.3,130.6,137.7,151.5 |
6 | 28.7,81.3,118.5,122.0,122.7,123.0,123.2,125.8,126.8,127.6,127.7,128.1, 128.4,129.7,137.7,145.1,153.2 |
7 | 86.9,118.9,122.2,122.6,123.2,127.3,128.0,128.6,129.2,129.8,130.4,132.7, 137.4,143.9,153.2 |
8 | 79.9,118.2,122.4,123.0,123.4,126.5,127.9,128.4,128.7,129.9,130.3,134.2, 139.8,153.9 |
9 | 28.5,55.4,81.0,113.4,118.4,121.9,122.6,123.1,125.7,127.7,128.0,128.3, 129.6,129.7,137.2,138.1,153.1,158.9 |
10 | 72.8,110.5,118.2,122.5,122.6,123.2,126.2,128.0,129.1,129.9,130.1,131.5, 143.4,152.8,153.0 |
11 | 82.7,118.7,122.5,122.6,122.8,123.2,126.3,126.9,127.2,127.8,128.0,128.4, 128.8,129.1,129.8,130.0,132.1,133.8,135.8,136.3,147.2,152.6 |
12 | 26.5,79.6,108.9,111.5,118.2,119.3,122.0,122.5,122.7,123.2,124.9,128.1, 128.4,129.5,129.8,132.1,136.9,142.3,152.3,153.0 |
13 | 29.9,40.0,90.7,118.6,122.1,122.3,123.1,123.2,125.2,125.6,127.3,128.0, 128.3,129.5,129.7,137.7,144.2,145.2,153.4 |
14 | 27.2,66.5,67.6,68.6,68.9,69.5,78.9,95.0,118.2,121.8,121.9,122.6,123.0, 125.2,127.9,128.0,128.7,129.7,139.2,153.1 |
15 | 66.9,67.9,68.8,68.9,69.3,76.5,88.4,118.0,122.1,122.2,123.0,123.2,125.9, 127.7,128.5,129.6,129.8,134.3,153.8 |
16 | 87.5,118.8,120.4,122.5,123.1,125.1,125.4,128.3,128.5,128.8,129.8,129.9, 135.5,139.9,147.5,154.0 |
17 | 97.7,116.9,118.5,119.8,121.2,121.5,122.1,122.2,122.7,123.1,127.3,128.2, 128.4,129.0,130.0,130.2,132.3,150.4,150.6 |
18 | 97.8,112.7,118.3,118.5,120.0,121.2,121.5,122.2,122.7,123.0,124.1,127.2, 127.5,128.1,128.8,129.2,129.8,130.0,130.5,132.3,148.6,150.4 |
19 | 100.9,118.4,121.0,122.0,122.8,123.0,127.8,128.6,129.9,130.1,131.8,133.7, 150.4 |
20 | 22.8,28.4,29.9,53.2,107.1,117.4,119.3,120.9,121.0,121.9,122.2,122.6, 127.5,127.9,128.4,128.6,129.3,130.1,131.8,136.7,149.4,155.0 |
21 | 25.3,27.6,79.7,118.0,119.7,121.2,123.8,125.3,125.4,125.7,127.0,128.1, 128.2,128.4,128.5,129.3,129.5,130.1,130.5,130.8,133.7,141.4,153.8 |
22 | 30.1,83.4,118.7,119.5,123.3,123.7,125.2,125.4,126.0,126.4,127.0,127.2, 127.5,127.9,128.1,128.2,128.3,129.4,130.0,130.2,130.7,134.0,139.1,144.4, 154.2 |
23 | 22.1,25.8,32.5,35.0,80.1,118.5,119.6,120.9,123.7,125.1,125.3,125.6, 126.0,127.0,128.1,128.4,128.5,129.4,130.0,130.5,130.8,133.6,141.7,153.1 |
24 | 27.2,27.6,32.2,33.8,33.9,35.2,36.2,37.9,383.,84.4,119.8,120.6,123.2, 123.8,125.1,125.3,125.7,127.0,127.3,128.1,128.2,128.5,129.6,129.9,130.1, 130.8,133.8,140.0,152.2 |
25 | 89.2,118.6,119.7,123.7,125.2,125.4,125.7,126.1,127.0,127.3,127.7,128.0, 128.1,128.3,128.4,129.0,129.4,130.2,130.5,134.0,139.6,141.8,145.0,153.6 |
26 | 83.2,118.5,123.4,124.2,125.6,125.7,126.0,127.2,127.5,127.9,128.0,128.6, 128.9,129.0,130.5,130.6,130.9,134.3,137.4,138.6,155.7 |
27 | 22.8,67.7,68.0,69.5,70.0,81.3,94.7,117.8,120.0,123.2,123.8,125.0,125.1, 125.4,125.6,127.1,127.8,128.1,128.3,128.5,128.8,130.3,130.5,130.7,133.7, 141.6,153.2 |
28 | 66.7,68.1,69.2,69.6,69.9,79.2,86.2,118.2,118.7,119.6,122.9,124.1,125.4, 125.8,126.8,127.2,127.8,128.0,128.2,128.5,128.8,130.1,130.5,131.0,134.2, 137.5,156.2 |
29 | 89.1,119.2,120.1,120.2,120.6,122.8,124.2,124.9,125.5,125.8,126.1,126.6, 127.1,127.6,128.1,128.3,128.4,128.8,129.5,130.0,130.3,130.4,130.7,131.0, 134.4,138.8,139.5,141.5,145.9,146.9,155.2 |
30 | 98.5,116.9,119.4,120.1,121.5,122.2,123.6,124.2,125.4,126.3,126.4,126.7, 127.0,127.1,127.3,127.5,128.1,128.4,128.6,129.0,129.1,130.2,130.6,130.9, 133.5,134.5,150.2,150.4 |
31 | 98.6,113.0,117.0,118.2,119.4,119.7,120.1,121.5,123.7,124.2,124.4,124.7, 125.5,125.7,126.7,127.2,127.5,128.4,128.6,128.8,129.1,129.9,130.6,130.7, 130.9,133.4,134.5,148.5,150.1 |
32 | 101.4,1116.9,118.3,118.6,119.3,121.0,122.0,122.9,123.0,123.3,124.2, 124.3,125.0,125.4,125.5,125.7,126.8,127.5,127.7,128.3,128.7,128.8,129.1, 129.9,130.1,130.7,131.1,131.4,133.2,134.4,134.9,150.2 |
33 | 23.9,28.6,30.1,51.6,106.5,109.5,116.8,119.1,119.4,121.8,123.8,125.0, 125.2,125.5,126.3,126.8,127.8,128.0,128.3,128.5,128.9,129.2,130.1,130.6, 130.8,132.8,134.4,136.6,149.2,154.7 |
Molecular formula, productive rate and the ultimate analysis of table 3 compound 1-33
12 | C 20H 16O 2 | 72 | 83.32(83.31) | 5.66(5.59) | Do not have |
13 | C 21H 16O | 55 | 88.72(88.70) | 5.76(5.67) | Do not have |
14 | C 24H 20FeO | 57 | 75.40(75.81) | 5.03(5.30) | Do not have |
15 | C 23H 18FeO | 68 | 75.12(75.43) | 4.67(4.95) | Do not have |
16 | C 25H 16O | 68 | 90.47(90.33) | 4.90(4.85) | Do not have |
17 | C 21H 14O 2 | 66 | 84.59(84.54) | 4.89(4.73) | Do not have |
18 | C 25H 16O 2 | 67 | 86.11(86.19) | 4.73(4.63) | Do not have |
19 | C 25H 16O 2 | 76 | 86.28(86.19) | 4.44(4.63) | Do not have |
20 | C 23H 21NO | 78 | 84.17(84.37) | 6.49(6.46) | 3.97(4.28) |
21 | C 23H 18O | 72 | 88.89(89.00) | 5.60(5.85) | Do not have |
22 | C 28H 20O | 81 | 90.28(90.29) | 5.44(5.41) | Do not have |
23 | C 26H 22O | 79 | 89.00(89.11) | 6.29(6.33) | Do not have |
24 | C 30H 26O | 83 | 89.85(89.51) | 6.80(6.51) | Do not have |
25 | C 33H 22O | 76 | 90.88(91.21) | 4.95(5.10) | Do not have |
26 | C 27H 18O | 78 | 90.42(90.47) | 5.40(5.06) | Do not have |
27 | C 32H 24FeO | 58 | 79.64(80.01) | 4.55(5.04) | Do not have |
28 | C 31H 22FeO | 62 | 79.72(79.84) | 4.40(4.75) | Do not have |
29 | C 33H 20O | 86 | 91.89(91.64) | 4.60(4.66) | Do not have |
30 | C 29H 18O 2 | 67 | 87.47(87.42) | 4.11(4.55) | Do not have |
31 | C 33H 20O 2 | 63 | 88.63(88.37) | 4.77(4.49) | Do not have |
32 | C 33H 20O 2 | 61 | 88.22(88.37) | 4.53(4.49) | Do not have |
33 | C 33H 25NO | 83 | 86.89(87.09) | 5.74(5.89) | 3.21(3.28) |
Fusing point and the mass-spectrometric data of table 3 compound 1-33
6 | 160-161 | 272(22,[M] +),257(100,[M-CH 3] +) |
7 | 130-131 | 334(16,[M] +),257(100,[M-C 6H 5] +) |
8 | 84-85 | 258(30,[M] +),257(14,[M-H] +),181(100,[M-C 6H 5] +) |
9 | 76-77 | 302(22,[M] +),287(100,[M-CH 3] +) |
10 | 65-66 | 248(100,[M] +),247(81,[M-H] +),181(41,[M-C 4H 3O] +) |
11 | 199-200 | 366(100,[M] +),283(19,[M-C 4H 3S] +) |
12 | 110-111 | 288(23,[M] +),273(100,[M-CH 3] +) |
13 | 92-93 | 284(100,[M] +) |
14 | 116-117 | 380(90,[M] +),365(100,[M-CH 3] +),195(25,[M-C 10H 9Fe] +) |
15 | 147-148 | 366(100,[M] +),365(31,[M-H] +),181(14,[M-C 10H 9Fe] +) |
16 | 302-303 | 332(100,[M] +) |
17 | 158-159 | 298(100,[M] +) |
18 | 222-223 | 348(100,[M] +) |
19 | 212-213 | 348(93,[M] +),180(100) |
20 | 234-235 | 327(65,[M] +),312(45,[M-CH 3] +),158(100) |
21 | 146-147 | 310(34,[M] +),295(100,[M-CH 3] +) |
22 | 196-197 | 372(83,[M] +),357(100,[M-CH 3] +),295(58,[M-C 6H 5] +) |
23 | 138-139 | 350(93,[M] +),307(100) |
24 | 247-248 | 402(87,[M] +),281(100) |
25 | 308-309 | 434(69,[M] +),357(100,[M-C 6H 5] +) |
26 | 213-214 | 358(96,[M] +),357(29,[M-H] +),281(74,[M-C 6H 5] +),80(100) |
27 | 178-179 decomposes | 480(100,[M] +),465(8,[M-CH 3] +),295(5,[M-C 10H 9Fe] +) |
28 | 200-201 | 466(62,[M] +),465(5,[M-H] +),281(4,[M-C 10H 9Fe] +),121(100) |
29 | 278-279 | 432(100,[M] +) |
30 | 231-232 | 398(53,[M] +),381(100) |
31 | 295-296 | 448(63,[M] +),431(100) |
32 | 220-221 | 448(39,[M] +),321(100) |
33 | 196-197 | 427(22,[M] +),412(5,[M-CH 3] +),158(100) |
Claims (4)
1, a kind of dibenzopyrans and dibenzo spiro-pyrans compounds is characterized in that it is that general formula is the compound of (I):
R wherein
1, R
2: hydrogen atom, contain 1 to 20 carbon aliphatics substituting group, aromatic substituents, contain the aliphatics substituting group or the aromatic substituents of 1 to 20 carbon of aerobic, nitrogen, sulfur heteroatom; R
1, R
2Can Cheng Huan, be aliphatics substituting group, the aromatic substituents that contains 1 to 20 carbon, aliphatics substituting group or the aromatic substituents that contains 1 to 20 carbon of aerobic, nitrogen, sulfur heteroatom; R
1, R
2Can be identical, also can be different.
2, a kind of dinaphthopyran and dinaphtho spiro-pyrans compounds is characterized in that it is that general formula is the compound of (II):
R wherein
1, R
2: hydrogen atom, contain 1 to 20 carbon aliphatics substituting group, aromatic substituents, contain the aliphatics substituting group or the aromatic substituents of 1 to 20 carbon of aerobic, nitrogen, sulfur heteroatom; R
1, R
2Can Cheng Huan, be aliphatics substituting group, the aromatic substituents that contains 1 to 20 carbon, aliphatics substituting group or the aromatic substituents that contains 1 to 20 carbon of aerobic, nitrogen, sulfur heteroatom; R
1, R
2Can be identical, also can be different.
3, the preparation method of dibenzopyrans as claimed in claim 1 or 2 and dibenzo spiro-pyrans compounds, dinaphthopyran and dinaphtho spiro-pyrans compounds is: by diphenylene-oxide or dinaphtho furans and lithium by 1: the 2-2.4 molar ratio reaction, open loop, react with aldehyde, ketone, ester or acid amides at-70 ℃ to-80 ℃ then, the mol ratio of diphenylene-oxide or dinaphtho furans and aldehyde, ketone, ester or acid amides is 1: 0.7-1, dehydration closed-loop forms corresponding dibenzo, dinaphthopyran and dibenzo, dinaphtho spiro-pyrans compounds again.
4, dibenzopyrans as claimed in claim 1 or 2 and dibenzo spiro-pyrans compounds, dinaphthopyran p and the application of dinaphtho spiro-pyrans compounds on medicine and photochromic material.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100140498A CN100432067C (en) | 2006-06-05 | 2006-06-05 | Dibenzanthracene, dinaphthopyran and dibenzanthracene, dinaphtho spiropyran analog compound and its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100140498A CN100432067C (en) | 2006-06-05 | 2006-06-05 | Dibenzanthracene, dinaphthopyran and dibenzanthracene, dinaphtho spiropyran analog compound and its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1884277A true CN1884277A (en) | 2006-12-27 |
CN100432067C CN100432067C (en) | 2008-11-12 |
Family
ID=37582594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100140498A Expired - Fee Related CN100432067C (en) | 2006-06-05 | 2006-06-05 | Dibenzanthracene, dinaphthopyran and dibenzanthracene, dinaphtho spiropyran analog compound and its preparation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100432067C (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103012353A (en) * | 2012-09-13 | 2013-04-03 | 华东理工大学 | Simple and convenient novel method for synthesizing 5,6-dibenzo(B,D)pyran and derivatives thereof |
WO2019093623A1 (en) * | 2017-11-10 | 2019-05-16 | 주식회사 엘지화학 | Novel heterocyclic compound and organic light-emitting diode using same |
WO2019112143A1 (en) * | 2017-12-06 | 2019-06-13 | 주식회사 엘지화학 | Novel heterocyclic compound and organic light emitting device using same |
CN114621205A (en) * | 2022-03-11 | 2022-06-14 | 京东方科技集团股份有限公司 | Derivative of oxygen-containing heterocyclic compound, light-emitting device, and display device |
TWI780043B (en) * | 2016-03-10 | 2022-10-11 | 日商三菱瓦斯化學股份有限公司 | Synthetic resin laminate having photochromic properties and lens using the same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3704915A1 (en) * | 1987-02-17 | 1988-08-25 | Hoechst Ag | ELECTROCHEMICAL METHOD FOR REPLACING HALOGENATOMS IN AN ORGANIC COMPOUND |
-
2006
- 2006-06-05 CN CNB2006100140498A patent/CN100432067C/en not_active Expired - Fee Related
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103012353A (en) * | 2012-09-13 | 2013-04-03 | 华东理工大学 | Simple and convenient novel method for synthesizing 5,6-dibenzo(B,D)pyran and derivatives thereof |
TWI780043B (en) * | 2016-03-10 | 2022-10-11 | 日商三菱瓦斯化學股份有限公司 | Synthetic resin laminate having photochromic properties and lens using the same |
WO2019093623A1 (en) * | 2017-11-10 | 2019-05-16 | 주식회사 엘지화학 | Novel heterocyclic compound and organic light-emitting diode using same |
CN111094261A (en) * | 2017-11-10 | 2020-05-01 | 株式会社Lg化学 | Novel heterocyclic compound and organic light emitting device using the same |
CN111094261B (en) * | 2017-11-10 | 2023-06-09 | 株式会社Lg化学 | Novel heterocyclic compound and organic light-emitting device using same |
WO2019112143A1 (en) * | 2017-12-06 | 2019-06-13 | 주식회사 엘지화학 | Novel heterocyclic compound and organic light emitting device using same |
CN114621205A (en) * | 2022-03-11 | 2022-06-14 | 京东方科技集团股份有限公司 | Derivative of oxygen-containing heterocyclic compound, light-emitting device, and display device |
CN114621205B (en) * | 2022-03-11 | 2024-03-08 | 京东方科技集团股份有限公司 | Derivative of oxygen-containing heterocyclic compound, light-emitting device, and display device |
Also Published As
Publication number | Publication date |
---|---|
CN100432067C (en) | 2008-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10730838B2 (en) | Green preparation method for quinoline compounds | |
CN1884277A (en) | Dibenzanthracene, dinaphthopyran and dibenzanthracene, dinaphtho spiropyran analog compound and its preparation | |
MXPA06013381A (en) | Transthyretin stabilization. | |
CN101139319A (en) | Substituted quinoline trimer indene derivative and method for making same | |
CN104557800B (en) | 2-phenoxyl tetrahydrofuran (tetrahydropyrane) derivatives and application thereof in synthesis of penoxsulam | |
CN109423297B (en) | Dibenzothiophene liquid crystal compound and preparation method and application thereof | |
Kamila et al. | Application of directed metallation in synthesis. Part 3: studies in the synthesis of (±)-semivioxanthin and its analogues | |
CN107141258B (en) | Method for synthesizing side chain functionalized 4-acylpyrazole compound from cyclic ketohydrazone | |
JP2551434B2 (en) | 3,4-Dihydroxytetrahydrofuran carbonate and method for producing the same | |
CN107602462B (en) | Method for preparing hydroxy-2 (1H) -quinolinone | |
CN103554023B (en) | The synthetic method of acridine derivatives and the polycyclic acridine derivative of synthesis | |
CN110256401A (en) | A kind of selenizing benzothienyl compounds and its synthetic method | |
CN113264816B (en) | Spiro [ cyclopropane-1, 2' -indene ] -1',3' -diketone derivative and synthetic method thereof | |
CN109423298B (en) | Novel dibenzothiophene liquid crystal compound and preparation method and application thereof | |
CN101121701B (en) | Five-membered rings 3-position single-substituted benzosultam derivatives and preparation method thereof | |
CA1106850A (en) | 8h-indeno ¬ 2,1-b| thiophen-2-oxaminic acids and esters thereof | |
CN110272337B (en) | 6-gingerol derivative and preparation and application thereof | |
CN103113174A (en) | Preparation method of phenolic compounds | |
US5998652A (en) | Process for preparing 2-cyanobiphenyl compound | |
CN1071311C (en) | Process for manufacturing nitriles | |
CN109970703A (en) | The preparation method and application of 1,3- heterocyclic substituted aromatic ketone | |
CN105399762B (en) | A kind of synthetic method of benzo borate | |
Ito et al. | Quinolinecarboxylic acid based fluorescent molecules: ratiometric response to Zn2+ | |
CN114262308B (en) | 2-methylene-2, 3-dihydrothiazole compound and synthetic method and application thereof | |
TW305839B (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081112 |